Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06988774 · ClinicalTrials.gov registry record · NA
Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
A NA study of Myomectomy and Fallopian Tube Patency Tests, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06988774 is a NA study of Myomectomy and Fallopian Tube Patency Tests that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06988774, a NA study of Myomectomy and Fallopian Tube Patency Tests, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study uses a procedure called chromopertubation to look at how fibroids and fibroid surgery affect the fallopian tubes. Specifically, this study will test if the fallopian tubes are occluded or patent (open) before and after surgically removing fibroids. Chromopertubation is a commonly performed and well-established procedure that is done during laparoscopic surgery to determine if the fallopian tubes are open or blocked. It includes inserting a dilute solution of saline with a small amount of medical-grade blue dye (called methylene blue) into the uterine cavity to see if it spills out of the fallopian tubes. Chromopertubation is considered a safe procedure - the main risk is an allergic reaction to the dye, which is very rare. The minimum amount of methylene blue dye will be used to further reduce risks of a reaction. Open fallopian tubes are necessary to become pregnant without the use of IVF. While it is known that some conditions can affect the functioning of the fallopian tubes, there is a lack of research about how fibroids affect the tubes. It is also not known how much about how the process of removing fibroids may affect the fallopian tubes. The investigators hypothesize that tubal occlusion will be observed in patients with fibroids and that the frequency of tubal occlusion will change after myomectomy compared to pre-myomectomy. This study will be conducted entirely during planned surgery for laparoscopic myomectomy. Chromopertubation will be performed at the beginning and again at the end of the surgery. This is expected to take less than 10 minutes in total. The results of the chromopertubation as well as background medical information will be recorded and the characteristics of the fibroids (size, number, and location) will be compared to the presence or abscence of tubal occlusion as determined by chromopertubation.
Conditions Studied
Interventions
- PROCEDURE chromopertubation
Study Locations (1)
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-02 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06988774
The ClinicalTrials.gov registry entry for NCT06988774 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Myomectomy appearing as the primary indexed condition, and to 1 intervention - of which chromopertubation is the first listed.
NCT06988774 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06988774 about?
NCT06988774 is a clinical study titled "Assessment of Tubal Occlusion During Minimally Invasive Myomectomy". This study uses a procedure called chromopertubation to look at how fibroids and fibroid surgery affect the fallopian tubes. Specifically, this study will test if the fallopian tubes are occluded or patent (open) before and after surgically removing fibroids. Chromopertubation is a commonly perform...
What is the current status of trial NCT06988774?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-02. Estimated completion is 2026-04-30.
What conditions does trial NCT06988774 study?
This clinical trial studies the following conditions: Myomectomy, Fallopian Tube Patency Tests, Fibroid/Myoma (Uterus/Cervix), Fallopian Tube Disease.
What interventions are being tested in trial NCT06988774?
The interventions under investigation include: chromopertubation (PROCEDURE).
Who is sponsoring clinical trial NCT06988774?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06988774 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myomectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Myomectomy
All registered trials for this condition
Fallopian Tube Patency Tests
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.